Stockscreener 앱 받기
5.61
8.63%
-0.53
시간 외 거래:
5.72
0.11
+1.96%
Solid Biosciences Inc 주식(SLDB)의 최신 뉴스
SLDB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Solid Biosciences (SLDB) Stock Price, News & Analysis - MarketBeat
Biotech Sector Sustains After-Hours Trading Gains - Intellectia AI
Solid Biosciences (SLDB) Projected to Post Earnings on Thursday - MarketBeat
Solid Biosciences Inc. (NASDAQ:SLDB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Solid Biosciences Inc. sponsors international muscular dystrophy conference in Rome - Traders Union
SLDB SEC FilingsSolid Bioscience 10-K, 10-Q, 8-K Forms - Stock Titan
Solid Biosciences CTO Herzich sells $21k in shares By Investing.com - Investing.com South Africa
Solid Biosciences CEO Cumbo sells $96k in shares By Investing.com - Investing.com Canada
Solid Biosciences CTO Herzich sells $21k in shares - Investing.com India
Patterns Watch: What are Solid Biosciences Incs earnings expectationsMarket Activity Recap & Safe Entry Trade Signal Reports - baoquankhu1.vn
David Howton Sells 7,469 Shares of Solid Biosciences (NASDAQ:SLDB) Stock - MarketBeat
Insider Selling: Solid Biosciences (NASDAQ:SLDB) CEO Sells $96,868.08 in Stock - MarketBeat
Solid Biosciences (NASDAQ:SLDB) Insider Jessie Hanrahan Sells 4,134 Shares - MarketBeat
Insider Selling: Solid Biosciences (NASDAQ:SLDB) Director Sells 2,658 Shares of Stock - MarketBeat
Solid Biosciences CFO Tan sells $31k in shares - Investing.com Nigeria
Solid Biosciences CFO Tan sells $31k in shares By Investing.com - Investing.com Nigeria
Solid Biosciences COO Howton sells $43k in shares By Investing.com - Investing.com Nigeria
Solid Biosciences director’s wife sells $15k in shares By Investing.com - Investing.com Canada
Solid Biosciences chief regulatory officer Hanrahan sells $24k in SLDB stock - Investing.com Australia
Solid Biosciences COO Howton sells $43k in shares - Investing.com
Solid Biosciences (NASDAQ:SLDB) CFO Kevin Tan Sells 5,404 Shares - MarketBeat
Insider sale notice at Solid Biosciences (NASDAQ: SLDB) for RSU settlement - Stock Titan
Harahan Jessie files Form 144 to sell 4,134 SLDB shares (SLDB) - Stock Titan
Solid Biosciences supports Jett Foundation RareDiseaseDay event - Traders Union
Solid Biosciences Insiders Sold US$823k Of Shares Suggesting Hesitancy - simplywall.st
Solid Biosciences Highlights FDA Path for SGT-003 DMD Study, Shares Early Friedreich’s Ataxia Update - MarketBeat
Why is Solid Biosciences Inc. stock going upJuly 2025 Trends & Risk Managed Trade Strategies - mfd.ru
SLDB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
What analysts say about Solid Biosciences Inc. stockQuarterly Investment Review & Growth-Oriented Investment Plans - mfd.ru
Solid Biosciences (SLDB) Gets a Buy from Wedbush - The Globe and Mail
Adage discloses 1.8% Solid Biosciences (SLDB) ownership stake - Stock Titan
Citizens reiterates Market Outperform rating on Solid Biosciences stock - Investing.com Nigeria
Citizens reiterates Market Outperform rating on Solid Biosciences stock By Investing.com - Investing.com Canada
Solid Biosciences advances Duchenne treatment with FDA alignment By Investing.com - Investing.com Australia
Solid Biosciences advances Duchenne treatment with FDA alignment - Investing.com South Africa
Solid Biosciences: Positive FDA Meeting SGT-003 Sets Up Next Milestones (NASDAQ:SLDB) - Seeking Alpha
Needham Reiterates Buy Rating for Solid Biosciences (SLDB) at $1 - GuruFocus
Needham & Company LLC Reaffirms Buy Rating for Solid Biosciences (NASDAQ:SLDB) - MarketBeat
Solid Biosciences (SLDB) Gains FDA Alignment for Duchenne Trial - GuruFocus
Solid Biosciences Receives Positive FDA Feedback - Intellectia AI
Solid Biosciences To Dose First Patient In IMPACT DUCHENNE Phase 3 Trial In Q1'26 - Nasdaq
Solid Biosciences stock rises after FDA alignment on Phase 3 trial design - Investing.com Nigeria
Solid Biosciences (SLDB) Advances Duchenne Therapy with FDA Supp - GuruFocus
3.69%
0.68%
자본화:
|
볼륨(24시간):